Sean P. Nolan

Biography

    As Chief Business Officer of InterMune Inc.—a biotech company later acquired by Roche Holding AG—Mr. Nolan led multiple functions, including North American commercial operations, global marketing, corporate and business development, and global manufacturing and supply chain. He also planned and executed the U.S. launch of InterMune's treatment for idiopathic pulmonary fibrosis, a rare and fatal lung disease with no other approved treatments.As Chief Commercial Officer of Reata Pharmaceuticals, Inc., Mr. Nolan led the market strategy development and commercialization of the company's first in-class product pipeline.At Ovation Pharmaceuticals, Inc.—a company focused on orphan neurology diseases—Mr. Nolan held numerous management positions including President of Lundbeck Inc., a U.S. affiliate. Ovation Pharmaceuticals was acquired by H. Lundbeck A/S in March 2009.Sean P. Nolan holds a B.A. in biology from John Carroll University and also currently serves on the board of directors of Aquinox Pharmaceuticals, Inc.  

Research Interest